Similar articles

• DNA sequencing versus standard prenatal aneuploidy screening.

  Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, Oliver K, Rava RP, Sehnert AJ; CARE Study Group. Bianchi DW, et al. N Engl J Med. 2014 Feb 27;370(9):799-808. doi: 10.1056/NEJMoa1311037. N Engl J Med. 2014. PMID: 24571752
• DNA sequencing versus standard prenatal aneuploidy screening.

  Vrachnis N, Vlachadis N, Creatsas G. Vrachnis N, et al. N Engl J Med. 2014 Aug 7;371(6):578. doi: 10.1056/NEJMc1405486. N Engl J Med. 2014. PMID: 25099589 No abstract available.
• DNA sequencing versus standard prenatal aneuploidy screening.

  Liao C, Zhengfeng X, Zhang K. Liao C, et al. N Engl J Med. 2014 Aug 7;371(6):577-8. doi: 10.1056/NEJMc1405486. N Engl J Med. 2014. PMID: 25099588 No abstract available.
• Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.

  Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW. Lau TK, et al. Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10. Ultrasound Obstet Gynecol. 2014. PMID: 24339153 Review.
• Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.

  Wagner AJ, Mitchell ME, Tomita-Mitchell A. Wagner AJ, et al. Clin Perinatol. 2014 Dec;41(4):957-66. doi: 10.1016/j.clp.2014.08.013. Epub 2014 Oct 1. Clin Perinatol. 2014. PMID: 25459783 Review.